-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RZT+n0B+tJk1Ntuf5H5GmEKOdAjBjW5V/vv7BBfoJjzZ12XbqVE+uwM0NBw2Q78O HbF6ED5Fwob+lCIvga+JnQ== 0001187154-10-000053.txt : 20101210 0001187154-10-000053.hdr.sgml : 20101210 20101210165734 ACCESSION NUMBER: 0001187154-10-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101208 FILED AS OF DATE: 20101210 DATE AS OF CHANGE: 20101210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEPHALON INC CENTRAL INDEX KEY: 0000873364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232484489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 MOORES ROAD CITY: FRAZER STATE: PA ZIP: 19355 BUSINESS PHONE: 6103440200 MAIL ADDRESS: STREET 1: 41 MOORES ROAD CITY: FRAZER STATE: PA ZIP: 19355 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BALDINO FRANK JR CENTRAL INDEX KEY: 0001187154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19119 FILM NUMBER: 101245594 MAIL ADDRESS: STREET 1: C/O VIROPHARMA INC STREET 2: 405 EAGLEVIEW BLVD CITY: EXTON STATE: PA ZIP: 19341 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-12-08 0000873364 CEPHALON INC CEPH 0001187154 BALDINO FRANK JR 41 MOORES ROAD FRAZER PA 19355 1 1 0 0 Chairman and CEO Common Stock 2010-12-08 4 M 0 150000 51.125 A 682582 D Common Stock 2010-12-08 4 S 0 150000 64.09 D 532582 D Common Stock 3545 I by Trust Incentive Stock Option 51.125 2010-12-08 4 M 0 1955 0 D 2000-12-13 2010-12-13 Common Stock 1955 0 D Non-Qualified Stock Option 51.125 2010-12-08 4 M 0 148045 0 D 2000-12-13 2010-12-13 Common Stock 148045 0 D This price is a weighted average sale price. The prices at which the shares actually sold ranged from $63.75 to $64.61. The reporting person has provided to the issuer, and upon request will provide to any security holder of the issuer or to the SEC staff, information regarding the number of shares sold at each price within the range. Options vest 25% on each anniversary of grant and are fully vested 4 years from the date of grant. Options expire ten years from date of grant. Susan Z. Fitzpatrick, Attorney-in-Fact For: Frank Baldino, Jr. 2010-12-10 -----END PRIVACY-ENHANCED MESSAGE-----